TRPM2: a Multifunctional Ion Channel for Calcium Signalling
Overview
Authors
Affiliations
The transient potential receptor melastatin-2 (TRPM2) channel has emerged as an important Ca(2+) signalling mechanism in a variety of cells, contributing to cellular functions that include cytokine production, insulin release, cell motility and cell death. Its ability to respond to reactive oxygen species has made TRPM2 a potential therapeutic target for chronic inflammation, neurodegenerative diseases, and oxidative stress-related pathologies. TRPM2 is a non-selective, calcium (Ca(2+))-permeable cation channel of the melastatin-related transient receptor potential (TRPM) ion channel subfamily. It is activated by intracellular adenosine diphosphate ribose (ADPR) through a diphosphoribose hydrolase domain in its C-terminus and regulated through a variety of factors, including synergistic facilitation by [Ca(2+)](i), cyclic ADPR, H(2)O(2), NAADP, and negative feedback regulation by AMP and permeating protons (pH). In addition to its role mediating Ca(2+) influx into the cells, TRPM2 can also function as a lysosomal Ca(2+) release channel, contributing to cell death. The physiological and pathophysiological context of ROS-mediated events makes TRPM2 a promising target for the development of therapeutic tools of inflammatory and degenerative diseases.
Thermo-TRP regulation by endogenous factors and its physiological function at core body temperature.
Kashio M Physiol Rep. 2025; 13(1):e70164.
PMID: 39793986 PMC: 11723785. DOI: 10.14814/phy2.70164.
Celik C, Demir B, Cicek D, Kuloglu T, Artas G, Hancer S Arch Dermatol Res. 2025; 317(1):222.
PMID: 39792277 DOI: 10.1007/s00403-024-03728-0.
Navigating the Controversies: Role of TRPM Channels in Pain States.
Gandini M, Zamponi G Int J Mol Sci. 2024; 25(19).
PMID: 39408620 PMC: 11476983. DOI: 10.3390/ijms251910284.
Ying K, Hua N, Luo Y, Liu X, Liu M, Yang W Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024; 53(5):604-614.
PMID: 39343750 PMC: 11528149. DOI: 10.3724/zdxbyxb-2024-0257.
TLR4 induced TRPM2 mediated neuropathic pain.
Mandlem V, Rivera A, Khan Z, Quazi S, Deba F Front Pharmacol. 2024; 15:1472771.
PMID: 39329114 PMC: 11424904. DOI: 10.3389/fphar.2024.1472771.